Biodexa Pharmaceuticals Plc (BDRX): BDRX..BREAKING THE 50 DAY

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Biodexa Pharmaceuticals Plc (BDRX)

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	904
Posts	39684
Boards Moderated	7
Alias Born	03/22/2016

Re: TrendTrade2016 post# 77

Thursday, 03/28/2024 9:10:22 AM

Thursday, March 28, 2024 9:10:22 AM

BDRX..BREAKING THE 50 DAY

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent BDRX News

Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:29 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:29 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:28 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:28 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:27 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/02/2026 08:28:27 PM
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:17 AM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 09:00:06 PM
Preliminary Results for the Year Ended 31 December 2025 • GlobeNewswire Inc. • 03/27/2026 09:00:00 PM
Biodexa Launches Global Early Access Program for eRapa for FAP Patients Through Strategic Partnership with Tanner Pharma Group • GlobeNewswire Inc. • 03/23/2026 12:30:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/20/2026 09:19:51 PM
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/18/2026 09:11:41 PM
ADR Ratio Change • GlobeNewswire Inc. • 03/18/2026 09:00:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:20 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:18 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:15 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:30:12 PM
Biodexa Announces Support for Life’s a Polyp Foundation First U.S. Patient Advocacy Group for FAP Patients • GlobeNewswire Inc. • 03/09/2026 12:30:00 PM
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer • ACCESS Newswire • 02/19/2026 12:30:00 PM

More BDRX News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow